Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TV005 vaccine in healthy adults, adolescents, and children in Bangladesh
NCT02678455Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2016
- Primary completion
- Aug 2017
- Countries
- 1
01
Overview
A Phase 2 trial of TetraVax-DV in dengue fever, sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2016; status: completed.
02
Drugs
TetraVax-DV
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT02678455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02678455.